Search results for "Highlights"


 
Results 111 - 120 of about 267 for "Highlights".

Glucose-lowering agents other than metformin associated with higher mortality in study

Compared to matched controls, patients on metformin monotherapy did not show significant excess mortality during follow-up, but patients on sulfonylurea or insulin monotherapy had higher mortality rates.
January 2016

Diabetes, prior CHD may not be equivalent CHD risk factors, study indicates

The population-based prospective cohort analysis of adults who were members of a single U.S. health care delivery system compared CHD risk among those with and without a history of diabetes or CHD.
January 2016

Collaboration between generalists, subspecialists can improve glycemic control

A “virtual clinic” model involving consultations between diabetes subspecialists and primary care physicians was associated with glycemic improvements in treated patients and controls from the same practices, a British study found.
December 2015

Patients with prediabetes diagnosis more likely to change health behaviors

The authors stated that the impact of prediabetes awareness on the odds of adopting risk-reducing lifestyle factors highlights the special influence of physician input on patient behavior.
July 2015

Review compares once-weekly GLP-1 receptor agonists to other diabetes meds

Once-weekly glucagon-like peptide 1 (GLP-1) receptor agonists lower HbA1c without increasing body weight, a review found.
October 2015

Mortality in diabetes may vary greatly by age, glycemic control, renal complications

Patients who were under age 55 faced a more substantial increase in mortality risk from having diabetes than older patients.
November 2015

DPP-4 inhibitors associated with lower mortality and cardiac risk than sulfonylureas as add-on therapy, study finds

When added to metformin, DPP-4 inhibitors were associated with reduced risks for all-cause death and stroke but did not appear to alter the risks for myocardial infarction and hospitalization for heart failure relative to sulfonylureas.
November 2015

Metformin potentially underused among patients with mild kidney disease, study finds

More patients would be eligible for metformin use if estimated glomerular filtration rate were used to define kidney disease rather than serum creatinine, a recent study concluded.
September 2015

Diabetes prevalence remains high in U.S. adults

The estimated prevalence of diabetes among U.S. adults ranged between 12% and 14% in 2011-2012, according to a recent study.
September 2015

Pioglitazone use not associated with increased risk of bladder cancer, study finds

Pioglitazone was not found to be associated with a statistically significant increased risk of bladder cancer or 8 of 10 additional cancers in a recent study.
August 2015

Result Page: Prev   7   8   9   10   11   12   13   14   15   16   Next